S02 - RFQ_Attachment A_renal_36C26224Q0118.xlsx
XLSX spreadsheet 48 KB Posted
- Attached to
- Q301--Renal Diagnostic Testing-Tucson Federal contract opportunity
- Solicitation number
- 36C26224Q0118
About this file
This document appears to be an attachment to a request for quote (RFQ) from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 for renal diagnostic testing services in Tucson, Arizona. The attachment provides pricing templates for various clinical pathology laboratory (CPL) tests to be performed over a four year period, including surgical pathology of kidney biopsies, special staining, immunohistochemistry for initial and additional stains, immunofluorescence studies, and electron microscopy. The templates list the test codes, methodologies, required turnaround times for preliminary and additional results, quantities, and spaces to include unit prices and extended totals. However, the unit prices and extended totals are blank, indicating this is a template to be filled out by offerors responding to the RFQ. The location, accreditations, and other details for the performing laboratory are also to be provided by offerors.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| 36C26224Q0118 0001_1.docx | DOCX document | |
| S02- RFQ- Renal Biopsy SOW Attachment B_36C26224Q0118.pdf | ||
| 36C26224Q0118_1.docx | DOCX document | |
| S02 - RFQ - Urgent Renal Diagnostic_36C26224Q0118.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Base
| CLIN | CPT # | MEDIA | Methodology | Performing Laboratory Location (Include City, County & State) | Performaing Laboratory CAP & CLIA Accreditation | Contractor Turnaround Time (Hours) for Preliminary Results | Contractor Turnaround Time (Days) for Additional Consultations After Preliminary Results | Quantity (EA) | Unit Price | Extended Price |
| 0001 | 88305 | Surgical Pathology / Kidney Biopsy | 33 | $ - 0 | $ - 0 | |||||
| 0002 | 88313 | Special Stains, Group II | 101 | $ - 0 | $ - 0 | |||||
| 0003 | 88341 | IHC - Initial Stain | 2 | $ - 0 | $ - 0 | |||||
| 0004 | 88342 | IHC - Additional Stain | 11 | $ - 0 | $ - 0 | |||||
| 0005 | 88346 | Immunofluor Study EA Antibg: Direct | 33 | $ - 0 | $ - 0 | |||||
| 0006 | 88348 | Electron Microscopy | 33 | $ - 0 | $ - 0 | |||||
| 0007 | 88350 | Immunofluor Study EA Antibg: Direct + | 263 | $ - 0 | $ - 0 | |||||
| Total | $ - 0 |
OY1
| CLIN | CPT # | MEDIA | Methodology | Performing Laboratory Location (Include City, County & State) | Performaing Laboratory CAP & CLIA Accreditation | Contractor Turnaround Time (Hours) for Preliminary Results | Contractor Turnaround Time (Days) for Additional Consultations After Preliminary Results | Quantity (EA) | Unit Price | Extended Price |
| 1001 | 88305 | Surgical Pathology / Kidney Biopsy | 33 | $ - 0 | $ - 0 | |||||
| 1002 | 88313 | Special Stains, Group II | 101 | $ - 0 | $ - 0 | |||||
| 1003 | 88341 | IHC - Initial Stain | 2 | $ - 0 | $ - 0 | |||||
| 1004 | 88342 | IHC - Additional Stain | 11 | $ - 0 | $ - 0 | |||||
| 1005 | 88346 | Immunofluor Study EA Antibg: Direct | 33 | $ - 0 | $ - 0 | |||||
| 1006 | 88348 | Electron Microscopy | 33 | $ - 0 | $ - 0 | |||||
| 1007 | 88350 | Immunofluor Study EA Antibg: Direct + | 263 | $ - 0 | $ - 0 | |||||
| Total | $ - 0 |
OY2
| CLIN | CPT # | MEDIA | Methodology | Performing Laboratory Location (Include City, County & State) | Performaing Laboratory CAP & CLIA Accreditation | Contractor Turnaround Time (Hours) for Preliminary Results | Contractor Turnaround Time (Days) for Additional Consultations After Preliminary Results | Quantity (EA) | Unit Price | Extended Price |
| 2001 | 88305 | Surgical Pathology / Kidney Biopsy | 33 | $ - 0 | $ - 0 | |||||
| 2002 | 88313 | Special Stains, Group II | 101 | $ - 0 | $ - 0 | |||||
| 2003 | 88341 | IHC - Initial Stain | 2 | $ - 0 | $ - 0 | |||||
| 2004 | 88342 | IHC - Additional Stain | 11 | $ - 0 | $ - 0 | |||||
| 2005 | 88346 | Immunofluor Study EA Antibg: Direct | 33 | $ - 0 | $ - 0 | |||||
| 2006 | 88348 | Electron Microscopy | 33 | $ - 0 | $ - 0 | |||||
| 2007 | 88350 | Immunofluor Study EA Antibg: Direct + | 263 | $ - 0 | $ - 0 | |||||
| Total | $ - 0 |
OY3
| CLIN | CPT # | MEDIA | Methodology | Performing Laboratory Location (Include City, County & State) | Performaing Laboratory CAP & CLIA Accreditation | Contractor Turnaround Time (Hours) for Preliminary Results | Contractor Turnaround Time (Days) for Additional Consultations After Preliminary Results | Quantity (EA) | Unit Price | Extended Price |
| 3001 | 88305 | Surgical Pathology / Kidney Biopsy | 33 | $ - 0 | $ - 0 | |||||
| 3002 | 88313 | Special Stains, Group II | 101 | $ - 0 | $ - 0 | |||||
| 3003 | 88341 | IHC - Initial Stain | 2 | $ - 0 | $ - 0 | |||||
| 3004 | 88342 | IHC - Additional Stain | 11 | $ - 0 | $ - 0 | |||||
| 3005 | 88346 | Immunofluor Study EA Antibg: Direct | 33 | $ - 0 | $ - 0 | |||||
| 3006 | 88348 | Electron Microscopy | 33 | $ - 0 | $ - 0 | |||||
| 3007 | 88350 | Immunofluor Study EA Antibg: Direct + | 263 | $ - 0 | $ - 0 | |||||
| Total | $ - 0 |
OY4
| CLIN | CPT # | MEDIA | Methodology | Performing Laboratory Location (Include City, County & State) | Performaing Laboratory CAP & CLIA Accreditation | Contractor Turnaround Time (Hours) for Preliminary Results | Contractor Turnaround Time (Days) for Additional Consultations After Preliminary Results | Quantity (EA) | Unit Price | Extended Price |
| 4001 | 88305 | Surgical Pathology / Kidney Biopsy | 33 | $ - 0 | $ - 0 | |||||
| 4002 | 88313 | Special Stains, Group II | 101 | $ - 0 | $ - 0 | |||||
| 4003 | 88341 | IHC - Initial Stain | 2 | $ - 0 | $ - 0 | |||||
| 4004 | 88342 | IHC - Additional Stain | 11 | $ - 0 | $ - 0 | |||||
| 4005 | 88346 | Immunofluor Study EA Antibg: Direct | 33 | $ - 0 | $ - 0 | |||||
| 4006 | 88348 | Electron Microscopy | 33 | $ - 0 | $ - 0 | |||||
| 4007 | 88350 | Immunofluor Study EA Antibg: Direct + | 263 | $ - 0 | $ - 0 |
File details come from the government source that posted it. Updated .